Efficacy and Safety Prediction of Milrinone or Levosimendan as Initial Inotropic Drug Therapy in Patients With Acute and Advanced Heart Failure With Renal Insufficiency

NCT06205758 · clinicaltrials.gov ↗
UNKNOWN
Status
1600
Enrollment
OTHER
Sponsor class

Conditions

Sponsor

Yi Han

Collaborators